fda compounding semaglutide news september 2025 🚨 Moves to Permanently Shut Down Compounded GLP-1s The FDA is taking steps to eliminate large-scale of GLP-1 medications like and tirzepatide, signaling a major shift in how these FDA issued 25 warning letters

Let our skilled professionals pamper you and help you achieve a state of total relaxation and renewal

Preventing breakdown in inflamed GI lining (gastric ulcers, colitis models)

Patients who inadvertently use expired semaglutide should: Monitor blood glucose levels closely (for diabetes patients) to detect any loss of glycemic control Watch for injection site reactions such as increased redness, warmth, swelling, or pain that could indicate infection Contact their healthcare provider to report the incident and obtain guidance on next steps Obtain a fresh supply and resume treatment with properly stored, unexpired medication Healthcare providers should emphasize the importance of adhering to expiration guidelines

What the numbers actually look like These are approximate 2026 figures

Fletcher MM, Belousoff MJ, Harikumar KG, et al